DAWN FY 2021 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

DAWNDay One Biopharmaceuticals, Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$199,000

Operating Income

-$73M

Net Income

-$71M

EPS (Diluted)

$-1.14

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$57M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$290M

Total Liabilities

$9M

Stockholders' Equity

$281M

Cash & Equivalents

$284M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$199,000	-$155,000	-28.4%
Operating Income	-$73M	-$14M	-427.8%
Net Income	-$71M	-$41M	-74.4%